Name | [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate |
---|---|
Synonyms |
MS 1112
BETAMETHASONE BENZOATE Uticort (TN) Betamethasone benzoate Betamethasone 17-benzoate Benisone EINECS 244-897-9 W 5975 |
Description | Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU). |
---|---|
Related Catalog | |
In Vitro | Betamethasone 17-benzoate is the topical steroid[1]. Betamethasone 17-benzoate is a local corticosteroid[2]. A double-blind study of the effectiveness of Betamethasone 17-benzoate in the treatment of recurrent aphothous ulcers (RAU) is concucted. Betamethasone 17-benzoate is found to be effective in reducing symptoms and shortening healing time but not in preventing recurrences[3]. |
References |
Melting Point | 225-228° |
---|---|
Molecular Formula | C29H33FO6 |
Molecular Weight | 496.56700 |
Exact Mass | 496.22600 |
PSA | 100.90000 |
LogP | 3.76040 |
Vapour Pressure | 2.62E-17mmHg at 25°C |
RIDADR | UN 2811 6.1 / PGII |
---|